| 1. IDENTIFICATION & BASIC DESCRIPTION |
|
Cohort name
|
| |
Cohort of Workers Exposed to Ethylene Oxide
|
|
Country
|
| |
|
|
Name
|
| |
Kaitlin Kelly-Reif
|
|
Institution
|
| |
National Institute for Occupational Safety and Health
|
|
Email
|
| |
omp3@cdc.gov
|
|
Website
|
| |
- https://www.cdc.gov/niosh/pgms/worknotify/ethyleneoxide.html
|
|
Upload files
|
| |
|
|
Contact Principal Investigator (name)
|
| |
Please contact NIOSH by submitting the attached form
|
|
Upload files
|
| |
|
|
Participation in pooled analyses
|
| |
- The cohort is potentially interested in participating in pooled analyses of (European) occupational cohort studies (note pooled analyses also includes remote decentralized analyses that would not require any transfer of primary data as well as meta-analyses).
|
|
Main aim of cohort, please briefly describe the main objectives of the cohort
|
| |
Estimate the association between occupational exposure to ethylene oxide and causes of death
|
|
Study design (please select as many as appropriate)
|
| |
|
|
Comparators (please select as many as appropriate)
|
| |
- Internal study population
- External study population (includes SMR/SIR studies)
|
|
Inclusion criteria
|
| |
Potential exposure to ethylene oxide through employment at one of 14 US plants producing sterilized medical supplies and spices
|
|
Enrollment
|
| |
Completed
|
|
Men at enrollment
|
| |
8,214
|
|
Women at enrollment
|
| |
10,039
|
|
Children (<18 years) at enrollment
|
| |
0
|
| 2. OUTCOME FOLLOW-UP |
|
Type of data for outcome follow-up (please select as many as appropriate)
|
| |
|
|
Death certificate (specify)
|
| |
- Mortality is currently being updated though 2018
|
|
First follow-up period (provide year)
|
| |
1987
|
| 3. OCCUPATIONAL EXPOSURES |
|
Source of exposure data collected (please select as many as appropriate)
|
| |
|
|
Occupational history/time frame
|
| |
Follow-up period
|
|
Occupational coding performed
|
| |
No
|
|
Types of exposure measurements
|
| |
|
|
Methods for exposure assessment (please select as many as appropriate)
|
| |
- Data modelling
- Job Exposure Matrix
|
|
Main categories
|
| |
|
|
Other chemicals | Ethylene oxide
|
| |
|
| 4. OUTCOMES EVALUATED |
|
Baseline - type of outcome data collected (select more than one if applicable)
|
| |
|
|
Follow-up - type of outcome data collected (select more than one if applicable)
|
| |
- Death certificates
- Medical records
- Questionnaire, individual (self-recording or interview)
|
|
Outcome type (please select as many as appropriate)
|
| |
|
|
Diagnostic groups based on ICD10
|
| |
|
|
C + D Neoplasms
|
| |
- Benign neoplasm
- Carcinoma in situ
- Leukemia
- Malignant neoplasms gastro intes. system including liver, gall bladder, pancreas
- Malignant neoplasm lung
- Mesothelioma
- Other malignant neoplasm of respiratory and intrathoracic organs, heart, pleura
- Malignant neoplasm of bone and articular cartilage
- Melanoma and other malignant neoplasms of skin
- Neoplasms connective and soft tissue including nerves
- Malignant neoplasm of breast
- Malignant neoplasms, females gynecological
- Malignant neoplasms of male genital organs
- Malignant neoplasm of urinary tract and kidney
- Malignant neoplasms of eye, brain and other parts of central nervous system
- Malignant neoplasms of thyroid and other endocrine glands
- Malignant neoplasms of ill-defined, secondary and unspecified sites
- Malignant neoplasm without specification of site including excl. leukemia
- Other, please state
|
| 6. Other Information |
|
Possibility for linkage to data registries/data enrichment via data linkage
|
| |
- Cancer incidence
- Mortality register
|